The Current Ratio as of November 2024 (TTM) for BiondVax Pharmaceuticals Ltd. (BVXV) is 6.15

According to BiondVax Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 6.15. This represents a change of 21.14% compared to the average of 5.07 of the last 4 quarters.

BiondVax Pharmaceuticals Ltd. (BVXV) Historical Current Ratio (quarterly & annually)

How has BVXV Current Ratio performed in the past?

The mean historical Current Ratio of BiondVax Pharmaceuticals Ltd. over the last ten years is 9.15. The current 6.15 Current Ratio has changed 6.62% with respect to the historical average. Over the past ten years (40 quarters), BVXV's Current Ratio was at its highest in in the June 2014 quarter at 43.90. The Current Ratio was at its lowest in in the March 2020 quarter at -1.54.

BiondVax Pharmaceuticals Ltd. (BVXV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BiondVax Pharmaceuticals Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BiondVax Pharmaceuticals Ltd. (BVXV) Average Current Ratio

How has BVXV Current Ratio performed in the past?

The current Current Ratio of BiondVax Pharmaceuticals Ltd. (BVXV) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

BiondVax Pharmaceuticals Ltd. (BVXV) Current Ratio vs. Peers

How is BVXV’s Current Ratio compared to its peers?

BiondVax Pharmaceuticals Ltd.’s Current Ratio is greater than First Wave BioPharma, Inc. (1.21), less than Salarius Pharmaceuticals, Inc. (7.73), greater than SAB Biotherapeutics, Inc. (3.69), greater than Vaccinex, Inc. (0.77), greater than GeoVax Labs, Inc. (4.17), less than Molecular Partners AG (14.33), less than Mineralys Therapeutics, Inc. (8.55), less than AN2 Therapeutics, Inc. (9.75), less than Pharvaris N.V. (19.08), less than PepGen Inc. (8.47), greater than Can-Fite BioPharma Ltd. (2.93), greater than Oramed Pharmaceuticals Inc. (2.25), greater than MediWound Ltd. (1.65), greater than BioLineRx Ltd. (1.61), less than Surrozen, Inc. (7.40), greater than Armata Pharmaceuticals, Inc. (0.19), less than Pasithea Therapeutics Corp. (14.81), greater than Oncternal Therapeutics, Inc. (2.39), greater than Aditxt, Inc. (0.09), less than Adial Pharmaceuticals, Inc. (6.78), greater than TransCode Therapeutics, Inc. (1.58), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Avenue Therapeutics, Inc. (2.67),

Build a custom stock screener for BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiondVax Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BiondVax Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.